
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Grunenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grunenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe
Grunenthal meds operates in the Pharmaceutical manufacturing industry.
Grunenthal meds's revenue is 11m - 100m
Grunenthal meds has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.